The table below shows AMICUS THERAPEUTICS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Q1 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
$149.59M
$139.47M
$113.55M
$128.24M
$115.41M
$96.84M
R&D
-
-
-
-
-
-
SG&A
FOLD annual revenue (10-K history)
AMICUS THERAPEUTICS, INC. reported annual revenue of $634.21M for fiscal year 2025. That is up 20.0% from $528.29M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.22M (FY 2014) to $634.21M. Figures come from the company's audited annual reports as filed with the SEC.
